Rx patent monopoly and Lizzo TM win
Please join us Monday, March 6, 2023 where we will discuss Rx patent monopoly issues and Lizzo's TM win. Specific case discussions will include: AbbVie Rx Patent Monopoly Strategy Against Biosimilars - AbbVie makes Humera for arthritis and extended its monopoly for 7 years past the 2016 expiration date of its basic patent on the [...]